Polina Shindiapina

Hematology
460 W 10th Ave
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.

Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy
Published: April 22, 2026

PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis.

PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis.

Journal: Blood advances
Published: May 21, 2024

Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.

Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.

Journal: EJHaem
Published: July 25, 2023

Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder.

Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder.

Journal: Cancers
Published: April 06, 2023

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

Journal: Cancers
Published: December 28, 2022

Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.

Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.

Journal: Journal of personalized medicine
Published: May 10, 2022

Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.

Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.

Journal: Journal of clinical medicine
Published: January 16, 2022

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.

Journal: Frontiers in immunology
Published: April 25, 2021

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease.

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease.

Journal: Vaccines
Published: April 19, 2021

Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia.

Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: November 19, 2020

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.

Journal: Blood advances
Published: June 25, 2020

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals.

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals.

Journal: Frontiers in oncology
Published: January 25, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026